Literature DB >> 1574592

The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer.

M B Barton1, T J Keane, T Gadalla, E Maki.   

Abstract

A significant effect of overall treatment time on local control was found in a retrospective review of 1012 radically irradiated squamous cell carcinomas of the larynx. The actuarial local relapse free rate (LRFR) at 5 years for the whole group was 59%. The effect of treatment time on local control was modelled to the linear-quadratic equation. Using logistic regression analysis treatment time and dose were significant (p = 0.008 and p = 0.04, respectively). When the analysis was adjusted for the influence of stage and laryngeal subsite treatment time remained a significant prognostic factor (p = 0.02). The derived value of gamma/alpha was 0.7 Gy/day and when adjusted for stage and sub-site 0.8 Gy/day. This equates to a dose increment to maintain iso-effective local control of 0.64 Gy/day and 0.73 Gy/day respectively for daily fractions of 2.5 Gy and an assumed alpha/beta for tumour of 25 Gy. To provide an estimate of the clinical impact of treatment interruptions not compensated for by dose escalation a Cox regression was performed. Significant variables were T stage, N stage, sex, total dose and total length of treatment interruption. Using the proportional hazard model it was calculated that each day of treatment interruption resulted in an increase in the hazard of local relapse by 4.8% (p = 0.006). Based on our data it was calculated that this would result in a decrease in local control of 1.4% for each day of uncompensated treatment interruption.

Entities:  

Mesh:

Year:  1992        PMID: 1574592     DOI: 10.1016/0167-8140(92)90323-m

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  22 in total

1.  Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays.

Authors:  M Maciá I Garau; J Solé Monné; M J Cambra Serés; C Monfà Binefa; M Peraire Llopis
Journal:  Clin Transl Oncol       Date:  2009-05       Impact factor: 3.405

2.  The "rocky treatment course": identifying a high-risk subgroup of head and neck cancer patients for supportive interventions.

Authors:  Horia Vulpe; Janet Ellis; Shao Hui Huang; Eshetu G Atenafu; Raymond W Jang; Gary Rodin; Jolie Ringash
Journal:  Support Care Cancer       Date:  2016-11-04       Impact factor: 3.603

3.  Radiation Duration in Women with Cervical Cancer Treated with Primary Chemoradiation: A Population-Based Analysis.

Authors:  Ana I Tergas; Alfred I Neugut; Ling Chen; William M Burke; Dawn L Hershman; Jason D Wright
Journal:  Cancer Invest       Date:  2016-03-17       Impact factor: 2.176

4.  High-dose rate intracavitary irradiation for carcinoma of the uterine cervix. The adverse effect of treatment prolongation.

Authors:  M Chatani; Y Matayoshi; N Masaki; T Inoue
Journal:  Strahlenther Onkol       Date:  1997-07       Impact factor: 3.621

5.  Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab.

Authors:  Shrujal S Baxi; Caitriona O'Neill; Eric J Sherman; Coral L Atoria; Nancy Y Lee; David G Pfister; Elena B Elkin
Journal:  Head Neck       Date:  2015-06-26       Impact factor: 3.147

6.  The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer.

Authors:  Talha Shaikh; Elizabeth A Handorf; Colin T Murphy; Ranee Mehra; John A Ridge; Thomas J Galloway
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-06       Impact factor: 7.038

7.  Radiation therapy for early glottic carcinoma (T1N0M0). The adverse effect of treatment interruption.

Authors:  M Chatani; Y Matayoshi; N Masaki; T Teshima; T Inoue
Journal:  Strahlenther Onkol       Date:  1997-10       Impact factor: 3.621

8.  Split-Course Radiotherapy in Stage IV Head & Neck Cancer.

Authors:  B M Biswal; N Ruzman; N M Ahmad; A Zakaria
Journal:  Malays J Med Sci       Date:  2000-01

9.  Pre-radiotherapy Haemoglobin Level is A Prognosticator in Locally Advanced Head and Neck Cancers Treated with Concurrent Chemoradiation.

Authors:  Rajesh Kar Narayanaswamy; Mahadev Potharaju; A N Vaidhyswaran; Karthikeyan Perumal
Journal:  J Clin Diagn Res       Date:  2015-06-01

10.  Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck.

Authors:  Silke Tribius; Stefanie Kronemann; Yasemin Kilic; Ursula Schroeder; Samer Hakim; Steven E Schild; Dirk Rades
Journal:  Strahlenther Onkol       Date:  2009-10-06       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.